IMPROVER: Involving Men with PROstate cancer in Engaged Research

2020

Prostate cancer is very common in Ireland, affecting one in six men. Dr Antoinette Perry’s research team is developing a better way to detect aggressive prostate cancer from a simple urine test (epiCaPture). Previously, they found that epiCaPture can catch nearly 90% of aggressive prostate cancers.

Now, the team want to “get outside of our lab” and engage with end-users of this potential new test, doctors and men living with prostate cancer from across different sectors of Irish society. They want to learn from end-users about their needs and opinions and feed this into epiCaPture development.

Publication:

Walsh M, Jordan A, Schäfer L, Joha J, Heapes B, Noonan M, Gallagher W, Gallagher H, Manecksha RP, Galvin D, Nason G, Martin T, Lyons C, O’Connor R; UCD Prostate Patient Advisory Committee; Drummond FJ, Kilty C, Perry AS. IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance. Clin Genitourin Cancer. 2024 Mar 4;22(3):102063. doi: 10.1016/j.clgc.2024.102063. Epub ahead of print. PMID: 38537420.

IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance – PubMed (nih.gov)